These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26926657)

  • 1. Does pharmacist-supervised intervention through pharmaceutical care program influence direct healthcare cost burden of newly diagnosed diabetics in a tertiary care teaching hospital in Nepal: a non-clinical randomised controlled trial approach.
    Upadhyay DK; Ibrahim MI; Mishra P; Alurkar VM; Ansari M
    Daru; 2016 Feb; 24():6. PubMed ID: 26926657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-clinical randomised controlled trial to assess the impact of pharmaceutical care intervention on satisfaction level of newly diagnosed diabetes mellitus patients in a tertiary care teaching hospital in Nepal.
    Upadhyay DK; Mohamed Ibrahim MI; Mishra P; Alurkar VM
    BMC Health Serv Res; 2015 Feb; 15():57. PubMed ID: 25888828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact assessment of pharmacist-supervised intervention on health-related quality of life of newly diagnosed diabetics: A pre-post design.
    Upadhyay DK; Mohamed Ibrahim MI; Mishra P; Alurkar VM
    J Pharm Bioallied Sci; 2020; 12(3):234-245. PubMed ID: 33100782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness and cost-utility analyses of hospital-based home care compared to hospital-based care for children diagnosed with type 1 diabetes; a randomised controlled trial; results after two years' follow-up.
    Tiberg I; Lindgren B; Carlsson A; Hallström I
    BMC Pediatr; 2016 Jul; 16():94. PubMed ID: 27421262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative DTM reduces hospitalization and healthcare costs in patients with diabetes treated with polypharmacy.
    Brophy L; Williams A; Berman EJ; Keleti D; Michael KE; Shepherd M; Fox SA; Jacobs C; Tan-Torres S; Gelzer AD; Tegenu M
    Am J Manag Care; 2014 Mar; 20(3):e72-81. PubMed ID: 24773329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of comorbidities on direct cost among type 2 diabetes mellitus (T2DM) patients in tertiary care government hospital in Uttarakhand, India: A primary data analysis of out of pocket expenditure.
    Nath B; Gupta SD; Kumari R
    Diabetes Metab Syndr; 2020; 14(6):2153-2159. PubMed ID: 33395775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a guideline-based clinical pathway of care to improve health outcomes following whiplash injury (Whiplash ImPaCT): protocol of a randomised, controlled trial.
    Rebbeck T; Leaver A; Bandong AN; Kenardy J; Refshauge K; Connelly L; Cameron I; Mitchell G; Willcock S; Ritchie C; Jagnoor J; Sterling M
    J Physiother; 2016 Apr; 62(2):111. PubMed ID: 26996096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hospital pharmacist-delivered individualised pharmaceutical service intervention on clinical and patient-reported outcomes in patients with hypertension: a randomised controlled trial.
    Paudel N; Shrestha S; Marasine NR; Khanal P; Aryal S; Erku D; Poudel A
    Eur J Hosp Pharm; 2023 Nov; 30(6):316-321. PubMed ID: 34980596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of diabetes.
    Dall TM; Zhang Y; Chen YJ; Quick WW; Yang WG; Fogli J
    Health Aff (Millwood); 2010 Feb; 29(2):297-303. PubMed ID: 20075080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated cost for cardiovascular disease risk-based management at a primary healthcare center in Nepal.
    Aryal A; Citrin D; Halliday S; Kumar A; Nepal P; Shrestha A; Nugent R; Schwarz D
    Glob Health Res Policy; 2020; 5():2. PubMed ID: 32016159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of hospitalization costs and its determinants in infants with clinical severe infection at a public tertiary hospital in Nepal.
    Shrestha S; Chapagain RH; Purakayastha DR; Basnet S; Wadhwa N; Strand TA; Basnet S
    PLoS One; 2021; 16(11):e0260127. PubMed ID: 34843530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups.
    Claus BO; Robays H; Decruyenaere J; Annemans L
    J Eval Clin Pract; 2014 Dec; 20(6):1172-9. PubMed ID: 25470782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
    Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
    Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pharmacist-led medication management in care transitions.
    Yang S
    BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.